Logo image of WOLF.CA

GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) Stock Fundamental Analysis

TSX-V:WOLF - TSX Venture Exchange - CA3978851044 - Common Stock - Currency: CAD

1.08  +0.01 (+0.93%)

Fundamental Rating

1

Overall WOLF gets a fundamental rating of 1 out of 10. We evaluated WOLF against 0 industry peers in the Unkown industry. Both the profitability and financial health of WOLF have multiple concerns. WOLF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WOLF had positive earnings in the past year.
WOLF had a positive operating cash flow in the past year.
WOLF.CA Yearly Net Income VS EBIT VS OCF VS FCFWOLF.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 1.81%
ROE 2.72%
ROIC 2.62%
ROA(3y)1.77%
ROA(5y)N/A
ROE(3y)-3.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOLF.CA Yearly ROA, ROE, ROICWOLF.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 10 -10 -20

1.3 Margins

Industry RankSector Rank
OM 6.48%
PM (TTM) 2.71%
GM 50.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WOLF.CA Yearly Profit, Operating, Gross MarginsWOLF.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 40

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WOLF is destroying value.
WOLF has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, WOLF has an improved debt to assets ratio.
WOLF.CA Yearly Shares OutstandingWOLF.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
WOLF.CA Yearly Total Debt VS Total AssetsWOLF.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M

2.2 Solvency

WOLF has an Altman-Z score of 2.64. This is not the best score and indicates that WOLF is in the grey zone with still only limited risk for bankruptcy at the moment.
WOLF has a debt to FCF ratio of 7.19. This is a slightly negative value and a sign of low solvency as WOLF would need 7.19 years to pay back of all of its debts.
WOLF has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 7.19
Altman-Z 2.64
ROIC/WACC0.34
WACC7.63%
WOLF.CA Yearly LT Debt VS Equity VS FCFWOLF.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M 10M 15M 20M 25M

2.3 Liquidity

WOLF has a Current Ratio of 3.22. This indicates that WOLF is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.11 indicates that WOLF has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.11
WOLF.CA Yearly Current Assets VS Current LiabilitesWOLF.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for WOLF have decreased strongly by -86.71% in the last year.
Looking at the last year, WOLF shows a small growth in Revenue. The Revenue has grown by 7.76% in the last year.
EPS 1Y (TTM)-86.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86%
Revenue 1Y (TTM)7.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOLF.CA Yearly Revenue VS EstimatesWOLF.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 5M 10M 15M 20M 25M
WOLF.CA Yearly EPS VS EstimatesWOLF.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

WOLF is valuated quite expensively with a Price/Earnings ratio of 54.00.
WOLF's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 54
Fwd PE N/A
WOLF.CA Price Earnings VS Forward Price EarningsWOLF.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 28.19
EV/EBITDA 12.45
WOLF.CA Per share dataWOLF.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WOLF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREY WOLF ANIMAL HEALTH CORP

TSX-V:WOLF (3/7/2025, 7:00:00 PM)

1.08

+0.01 (+0.93%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-24 2023-11-24
Earnings (Next)N/A N/A
Inst Owners12.67%
Inst Owner ChangeN/A
Ins Owners12.91%
Ins Owner ChangeN/A
Market Cap36.93M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 54
Fwd PE N/A
P/S 1.42
P/FCF 28.19
P/OCF 20.94
P/B 1.43
P/tB 12.84
EV/EBITDA 12.45
EPS(TTM)0.02
EY1.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY3.55%
OCF(TTM)0.05
OCFY4.78%
SpS0.76
BVpS0.75
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.81%
ROE 2.72%
ROCE 4.87%
ROIC 2.62%
ROICexc 3.24%
ROICexgc 15.91%
OM 6.48%
PM (TTM) 2.71%
GM 50.79%
FCFM 5.05%
ROA(3y)1.77%
ROA(5y)N/A
ROE(3y)-3.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 7.19
Debt/EBITDA 3.03
Cap/Depr 32.23%
Cap/Sales 1.75%
Interest Coverage 250
Cash Conversion 57.12%
Profit Quality 186.53%
Current Ratio 3.22
Quick Ratio 2.11
Altman-Z 2.64
F-Score6
WACC7.63%
ROIC/WACC0.34
Cap/Depr(3y)8.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y66.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y382.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y442.79%
OCF growth 3YN/A
OCF growth 5YN/A